Evaluation of pathomorphological changes and survival after selective intraarterial polychemotherapy of locally advanced breast cancer
DOI:
https://doi.org/10.26641/1997-9665.2011.1.13-23Keywords:
locally advanced breast cancer, selective intraarterial chemotherapy, neoadjuvant therapy, pathologic response, survivalAbstract
The pathomorphological changes (pathologic response) and survival of patients with locally advanced breast cancer (BC) were analyzed for the 89 patients treated with selective intraarterial polychemotherapy (PCT) in neoadjuvant mode and 46 treated with intravenous PCT in the same mode (control). More significant pathomorphological response after the treatment of BC in the neoadjuvant mode was achieved after selective intra-arterial PCT (p<0,01). In the intraarterial PCT group pathomorphosis grade 4 was observed in 16.9% (control – 8.70%), grade 3 – 37,0% (control – 28.3%), grade 2 – 46,1% (control – 26,1%). In the control group 1 degree pathomorphosis was in 26.1% of patients, no pathologic response – in 10,9%. In patients with pathomorphosis of 2-4 degrees in intraarterial PCT group 5-year survival increases by 0,90-5,60% compared with the control, 10-year-old survival – by 5,60-11,6%. Survival tended to increase with the degree of pathomorphosis without statistical differences in groups of intraarterial and intravenous PCT for each year of observation. The average life expectancy for the intraarterial PCT group was 4,61±0,02 years, for the control group – 4,19±0,05 (p<0,001). For 1-7 years difference in survival was within 5,8-9,5%. The best results are observed after seventh year: 7-10-year survival in intraarterial PCT group was 38.2%, in the control group – 23,9%.
References
- Бондарь Г. В. Первинно-неоперабельний рак молочної залози / Г. В. Бондарь, И. Е. Седаков, В. Г. Шлопов. – Донецьк: Каштан, 2005. – 348 с.
- Возможности управляемой регионарной васкуляризации при лечении местно-распространенного рака молочной железы / Г. В. Бондарь, В. Н. Смирнов, И. Е. Седаков [и др.] // Сб. науч. работ «Злокачеcтвенные новообразования», вып.2. – Киев: АТ «Телеоптик», 2002. – С. 19-20.
- Гистологический метод количественной оценки степени лучевого повреждения опухоли / Г. А. Лавникова, Т. Е. Гош, А. В. Талалаева [и др.] // Мед. радиология. – 1978. – № 3. – C. 6-9.
- Думанский Ю. В. Методы комбинированного и комплексного лечения метахронного рака молочной железы / Ю. В. Думанский, Ю. И. Яковец, А. В.Рогалев // Зaпорожский медицинский журнал. – 2004. - № 3. – С. 108-110.
- Клінічні аспекти резистентності раку молочної залози до антрациклінових антибіотиків / В. М. Півнюк, Ю. О. Тимовська, О. В. Пономарьова [та ін.] // Онкология. – 2009. – Т. 11, № 2. – С. 148-153.
- Лечение рака молочной железы Т3–4 N0M0 стадий [Электронный ресурс]/ К. В. Максимов, И. В. Высоцкая, В. Д. Ермилова [и др.] // Сайт Союза противораковых организаций России – Режим доступа к статье : http://netoncology.ru/ press/articles/561/1964
- Седаков И. Е. Селективная внутриартериальная полиxимиотерапия в комплексном лечении пeрвично-неоперабельного рака молочной железы / И. Е. Седаков // Архив клинической и экспериментальной медицины. – 1996. – Т. 5, № 1. – С. 23-27.
- Семиглазов В. Ф. Адъювантное химиолучевое лечение рака молочной железы / В. Ф.Семиглазов, В. В.Семиглазов // Практическая онкология. – 2008. – Т. 9, № 1. – С. 9-15.
- Смоланка И. И. Неоадъювантная гормонотерапия рака молочной железы I–IIIА стадии у женщин с сохраненной менструально-овариальной функцией как в монорежиме, так и в сочетании с лучевой терапией / И. И. Смоланка, О. И. Балашова, Я. В. Антоновская // Онкология. – 2006. – Т. 8, № 2. – С. 145-147.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2011 Bondar G.V., Sedakov I. E., Balashov O.I., Khomenko A.V., Morphologia

This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world.
The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.
